UC San Diego Health First in Region to Provide Novel Therapy for Melanoma
June 06, 2024
June 06, 2024
LA JOLLA, California, June 6 (TNSres) -- The University of California San Diego campus issued the following news:
Story by: Leslie Aquinde
UC San Diego Health is the first hospital system in the region to offer a new immunotherapy treatment for metastatic melanoma. The personalized cellular therapy derived from tumor infiltrating lymphocytes (TIL), is the first solid tumor therapy on the market approved by the U.S. Food and Drug Administration (FDA).
" . . .
Story by: Leslie Aquinde
UC San Diego Health is the first hospital system in the region to offer a new immunotherapy treatment for metastatic melanoma. The personalized cellular therapy derived from tumor infiltrating lymphocytes (TIL), is the first solid tumor therapy on the market approved by the U.S. Food and Drug Administration (FDA).
" . . .